Trial intelligence / Profile preview

STA-1 Capsule in Patients With Vascular Dementia

NCT01475578Phase 2Completed

Sponsor
Sinphar Pharmaceutical
Start
Mar 2002
Primary completion
Oct 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of STA-1 in vascular dementia, sponsored by Sinphar Pharmaceutical. Started Mar 2002; status: completed.

02

Drugs

STA-1
03

Conditions

vascular dementia

Beyond the preview

Go deeper on NCT01475578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01475578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call